Healthcare

The latest issue of Medical Imaging and Diagnostics TOE profiles innovations in the medical imaging and diagnostics industry. Some of the profiles covered include development of colored X-rays, artificial iris, next generation cancer imaging system, 3D nano-imaging, low-dose CT scan, and novel X-ray instrumentation. Medical Imaging and Diagnostics...

The latest edition of Medical Device TOE profiles innovations in orthobiologics, artificial intelligence in medical diagnosis, non-invasive health monitoring, and cybersecurity for medical devices. Innovations in focus include a supercomputer to understand the functioning of the brain, ECG patch for atrial fibrillation diagnosis, through-the-skin...

The Genetic Technology TechVision Opportunity Engine (TOE) depicts the current landscape and the new life sciences trends across precision medicine. Precision medicine strategies targeting mRNA splicing, novel therapies for inherited disorders, microbiome-based therapies for inflammatory diseases, and gene editing technologies fueling personalized ...

The Genetic Technology TechVision Opportunity Engine (TOE) outlines the impact of artificial intelligence (AI) on the global drug discovery and development landscape. Berg Health’s precision medicine platforms and a clinical overview of the company’s pipeline have been profiled in the TOE. Furthermore, IP trends, research aspects, and AI-medici...

The Genetic Technology TechVision Opportunity Engine (TOE) presents trends across diabetes care, CAR-T cell therapy, pedriatic and genetic disease treatment. Novel solutions for pancreatic islet transplants, CAR-T cell therapy, enzyme replacement therapy, and autism correlations are profiled. Clinical trials scenario for Alzheimer's disease is also...

Organ-on-a-chip technology involves the incorporation of microphysiological systems harboring dynamic living 3D organoids, tissue-culture, or cell cultures on a microfluidic platform. The physiologically relevant Organ-chip models offer a better and more precise insight to the possible in vivo effects of drugs in the human body. The flexibility of ...

Over the past several decades drug therapies for clinically safe and effective management of various types of pain, classified as being acute, chronic, breakthrough, nerve, and bone-related have been treated with the use of opioids, NSAIDS, anticonvulsants and antidepressants. However, increasing reliance on their use for prolonged intervals and si...

Healthcare industry has undergone major transformation in the last decade with the incorporation of digital technologies. The changing technological as well as social trends, which focuses more on consumerism of healthcare which includes personalized interventions, making patients more accountable for their healthcare, disease awareness, is aimed t...

Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...